Company Celgene

Stocks

CELG

Delayed Nasdaq Other stock markets 04:00:00 2019-11-20 pm EST			5-day change	1st Jan Change
108.24 ^USD	+0.10%		-1.97%	+68.89%

23-06-14	Sutro Biopharma, Inc. Receives a Notice of Termination from Celgene Corporation	CI
21-09-07	Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential Settlement Agreement with Celgene Corporation	CI

Business description: Celgene

Celgene Corporation specializes in the design, development, and sale of products for treating cancer and immune system disorders. Net sales break down by product family as follows:

- therapeutic products (99.9%);

- other (0.1%): cellular therapy products and biological materials for implants, for tissue and organ treatments, and for therapeutic product development.

Net sales are distributed geographically as follows: the United States (65.6%), Europe (24.7%) and other (9.7%).

Company details: Celgene

Celgene Corp.

86 Morris Avenue

07901, Summit

+(908) 673-9000

http://www.celgene.com

Group companies: Celgene

Name	Category and Sector
Celgene Logistics SARL
JUNO THERAPEUTICS INC	Biotechnology
Celgene International II SARL
Celgene International SARL Celgene International SARL Pharmaceuticals: MajorHealth Technology Operates as bio-pharmaceutical company, which discovers, develops and commercializes therapies for unmet medical needs in cancer	Pharmaceuticals: Major

See all subsidiaries

Sector

This company's sector is not yet available